Prognostic Significance of Left Ventricular Hypertrophy Regression
- 87 Downloads
In hypertension, left ventricular hypertrophy (LVH) is initially a useful compensatory process, that represents an adaptation to increased ventricular wall stress; however, it is also the first step toward the development of overt clinical disease, such as congestive heart failure, cardiac dysrrhythmias, and ischemic heart disease. In fact, the Framingham Study has shown that once LVH is recognized clinically it constitutes a powerful independent risk factor for future cardiovascular morbid events whether assessed by ECG or echocardiography, the latter being a specific, repeatable and far more sensitive measure of LVH1,2. The echocardiographic technique has demonstrated that the geometric adaptation of the left ventricle to increased cardiac load may be different among patients. Concentric hypertrophy is characterized by increased mass and increased relative wall thickness, whereas eccentric hypertrophy is characterized by increased mass and relative wall thickness < 0.45; on the other hand, concentric remodeling occurs when there is increased thickness with respect to radius, without increased LV mass. Concentric hypertrophy appears to carry the highest risk and eccentric hypertrophy an intermediate risk, whereas concentric remodeling is probably associated with a smaller, albeit still consistent risk3.
KeywordsLeave Ventricular Hypertrophy Left Ventricular Mass Relative Wall Thickness Concentric Hypertrophy Eccentric Hypertrophy
Unable to display preview. Download preview PDF.
- 6.Fouad FM, Nakashima Y, Tarazi RC, Salcedo EE. Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. lack of association to blood pressure control. Am J Cardiol, 49: 759–801 (1982).Google Scholar
- 10.Cruickshank J.M., Lewis J, Moore V, Dodd A. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J. Human Hypertens, 6: 85–90 (1992).Google Scholar
- 11.Agabiti-Rosei E, Muiesan ML, Castellano M. Methodology of studies on reversal of left ventricular hypertrophy. High Blood Press, 2(suppl 1): 11–13 (1993).Google Scholar
- 15.Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Emler P, Cutler JA, Flack JM, Schoenberger JA, McDonald R, Lewis CE, Liebson PR, on behalf of Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study. Final results. JAMA, 270: 713–724 (1993).PubMedCrossRefGoogle Scholar
- 16.Agabiti-Rosei E, Ambrosioni E, DalPalu’ C, Muiesan ML, Zanchetti A on behalf of the RACE Study group. Ace-inhibitor ramipril is more effective than β-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study. J Hypertens, 13: 1325–1335 (1995).PubMedCrossRefGoogle Scholar
- 17.Gottdiener JS, Reda DJ, Massie BM, Materson BJ, Williams DW, Anderson RJ, for the VA Cooperative Study group on antihypertensive Agents. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension Comparison of six antihypertensive agents. The Departement of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Circulation, 95: 2007–2014 (1997).PubMedCrossRefGoogle Scholar
- 21.Agabiti Rosei E. Romanelli G, Muiesan ML et al. Impaired response of the hypertrophied left ventricle to beta adrenergic stimulation in hypertensive patients. Circulation, 70(Suppl. II): 61 (1984).Google Scholar
- 24.Muiesan ML Rizzoni D, Rulli R, Calebich S, Malerba M, Porteri E, Agabiti-Rosei E. Effect of changes in blood pressure and left ventricular mass induced by antihypertensive treatment on ventricular arrhythmias in essential hypertension. J Hypertens, 11(suppl 5): s300–301 (1993).Google Scholar
- 27.Koren MJ, Savage DD, Casale PN, Laragh JH, Devereux RB. Changes in left ventricular mass predict risk in essential hypertension. Circulation, 82(suppl III): III29 (Abstract) (1990).Google Scholar